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findings, therefore, is crucial for an early 
therapeutic intervention, which can reduce 
the risk of tumor recurrence and serious 
complications. 
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 Introduction 
 Eccrine porocarcinoma is a rare malig-
nant tumor of the eccrine sweat gland, 
producing protean clinical and pathologic 
findings. The tumor was first described in 
1963 by Pinkus and Mehregan  [1] as epi-
dermotropic eccrine poroma. The term ec-
crine porocarcinoma was introduced in 
1969 by Mishima and Morioka  [2] , who 
identified the intraepidermal portion of 
the eccrine sweat duct (i.e. the acrosyrin-
gium) as the point of origin of this tumor. 
Since then, eccrine porocarcinomas have 
been reported in fewer than 300 cases 
worldwide  [3–5] .
 The peak incidence of porocarcinomas 
is in the seventh decade of life, and they 
appear to be slightly more common among 
males than females  [4] . Patients usually 
present with a nodule, a verrucous infiltra-
tive plaque, or an ulcerated polypoid lesion 
that is often mistaken for a squamous or 
basal cell carcinoma  [5] . However, eccrine 
porocarcinomas can also mimic many 
other cutaneous malignancies, including 
Bowen’s disease, amelanotic melanoma, 
cutaneous metastasis of a visceral carcino-
ma, or common benign lesions such as 
seborrheic keratosis, verruca vulgaris or 
pyogenic granuloma  [3, 5] . The diagnosis 
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 Abstract 
 Background: Eccrine porocarcinoma is a 
rare malignant tumor of the sweat gland, 
characterized by a broad spectrum of clini-
copathologic presentations. Surprisingly, 
unlike its benign counterpart eccrine poro-
ma, eccrine porocarcinoma is seldom found 
in areas with a high density of eccrine sweat 
glands, like the palms or soles. Instead, ec-
crine porocarcinoma frequently occurs on 
the lower extremities, trunk and abdomen, 
but also on the head, resembling various 
other skin tumors, as illustrated in the pa-
tients described herein.  Observations: We 
report 5 cases of eccrine porocarcinoma of 
the head. All patients were initially diag-
nosed as having epidermal or melanocytic 
skin tumors. Only after histopathologic ex-
amination were they classified as eccrine po-
rocarcinoma, showing features of epithelial 
tumors with abortive ductal differentiation. 
Characteristic clinical, histopathologic and 
immunohistochemical findings of eccrine 
porocarcinomas are illustrated.  Conclusion: 
Eccrine porocarcinomas are potentially fatal 
adnexal malignancies, in which extensive 
metastatic dissemination may occur. Poro-
carcinomas are commonly overlooked, or 
misinterpreted as squamous or basal cell 
carcinomas as well as other common malig-
nant and even benign skin tumors. Knowl-
edge of the clinical pattern and histologic 
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of eccrine porocarcinoma, therefore, most 
often relies upon identification of several 
of its more typical histopathologic and im-
munohistochemical features  [5–7] , as was 
the case with our patients.
 The potential for local recurrence and 
metastasis of eccrine porocarcinoma has 
been emphasized in many previous re-
ports and case series  [4, 8] . There is a high 
risk of multiple relapses and particularly 
intracranial or intracerebral extension, 
when eccrine porocarcinoma is localized 
on the head  [3, 8–10] . In the follow-up pe-
riod of our patients (18–30 months) no
tumor recurrences or metastases were ob-
served. Nevertheless, long-term surveil-
lance of eccrine porocarcinomas is re-
quired, because prognosis of the tumor is 
guarded  [4, 8, 11] . Here, a review of clinical 
and pathologic manifestations and cur-
rent treatment options for eccrine poro-
carcinoma are presented and discussed.
 Case Reports 
 Patient 1 
 A 64-year-old female patient with a 10-
year history of multiple myeloma was ad-
mitted to hospital with an exophytic tu-
mor of the head for evaluation of possible 
squamous or basal cell carcinoma. The tu-
mor had steadily increased for 4 years, but 
displayed a rapidly accelerated growth 
during the last 6 months. On examination, 
she had a partly erosive erythematous tu-
mor, with a sharp irregular border, ap-
proximately 3 cm in diameter and located 
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in the right submandibular region ( fig. 1 A). 
Computed tomography (CT) scans of the 
head, neck, trunk and abdomen revealed 
no metastases of a solid tumor. The patient 
underwent wide surgical excision of the 
skin lesion.
 Patient 2 
 This 77-year-old male patient present-
ed with a sharply bordered, hairless, exo-
phytic, red-brown tumor, 2 cm in diame-
ter on the vertex of his scalp with superfi-
cial erosion and crusting ( fig. 1 B). His 
admission was precipitated by rapid tumor 
growth for the last 2 months and frequent 
bleeding of the lesion after combing his 
hair. He denied any fevers, night sweat or 
weight loss. In this case, the tumor was
resected under the clinical diagnosis of 
squamous cell carcinoma or cutaneous 
metastasis. A neck ultrasound study, a 
chest radiograph as well as an abdominal 
ultrasound study showed no evidence of 
metastasis.
 Patient 3 
 An 80-year-old male patient was re-
ferred to our clinic with a 3-year history of 
a continuously growing and frequently 
bleeding tumor on the front of his scalp. 
Examination revealed a round, erythema-
tous, erosive tumor, approximately 3 cm
in diameter ( fig. 1 C). Four months before, 
the tumor had shown accelerated growth 
following a minor trauma. This tumor was 
initially interpreted as amelanotic mela-
noma or pyogenic granuloma. Before sur-
gical excision, a CT scan of the head and 
neck was done, which showed no signifi-
cant abnormality and no evidence of tu-
mor metastasis.
 Patient 4 
 This 78-year-old male patient with no 
notable medical history had a verrucous 
tumor on his left temporoparietal area 
( fig. 1 D). He reported a massive trauma of 
his scalp approximately 30 years ago and a 
1-year history of tumor development in 
the same location. He consulted a physi-
cian and, after a skin biopsy, a diagnosis of 
proliferating verruca vulgaris was made. 
On admission, he showed an irregularly 
but sharply bordered, exophytic, hyper-
keratotic tumor, approximately 4 cm in di-
ameter, resembling a cutaneous horn. A 
neck ultrasound study, chest radiography, 
as well as an abdominal ultrasound study, 
showed no evidence of metastasis, and a 
wide excision of the lesion was per-
formed.
 Patient 5 
 A 79-year-old male patient with a 12-
year history of chronic lymphocytic leuke-
mia who had had an exophytic tumor for 1 
year was admitted to our hospital for in-
vestigation. He also had multiple actinic 
keratoses on all light-exposed areas of the 
skin. Clinical examination revealed a 
partly erosive, multinodular tumor of ap-
proximately 3 cm in diameter, localized in 
the left retroauricular region with close as-
A B
C D
 Fig. 1. Clinical aspects of eccrine porocarcinoma.  A Partly erosive, erythematous tumor in patient 1 with mul-
tiple myeloma, mimicking squamous or basal cell carcinoma.  B Rapidly progressive, exophytic tumor with su-
perficial erosion and crusting in patient 2, mimicking squamous cell carcinoma or cutaneous metastasis.
 C Continuously growing, erosive tumor in patient 3, mimicking amelanotic melanoma or pyogenic granuloma. 
 D Conical, hyperkeratotic tumor with typical aspects of a cutaneous horn in patient 4, mimicking a proliferat-
ing verruca vulgaris. 
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sociation to his earlobe. The patient was 
given a presumptive diagnosis of squa-
mous cell carcinoma. A neck ultrasound 
study, CT scans of the head and neck, chest 
radiography and an abdominal ultrasound 
study were unremarkable. The patient un-
derwent wide local excision of the lesion.
 Histopathology and 
Immunohistochemistry 
 Histopathological examination of all 
tumors revealed features consistent with 
the diagnosis of eccrine porocarcinoma 
( fig. 2 A–F): solid aggregates of small epi-
thelial tumor cells replaced the epidermis 
and grew in anastomosing bands deep into 
the adjacent dermis. Peripheral nuclear 
palisading and retraction artifacts were 
not observed. All the tumors showed nu-
clear pleomorphism and prominent mitot-
ic activity with abnormal mitotic figures. 
Abortive ductal differentiation was evi-
dent in all tumors and could be highlight-
ed by epithelial membrane antigen as well 
as carcinoembryonic antigen immunohis-
tochemistry. Some tumor cells contained 
glycogen, sometimes producing foci of 
clear cell changes.
 Staging and Outcome 
 Initial and follow-up staging examina-
tions (including CT and ultrasound stud-
ies) showed no evidence of lymph node or 
visceral metastasis of any solid tumor. 
Furthermore, no local tumor recurrences 
were observed so far. However, it must be 
noted that the follow-up periods in our pa-
tients were rather short (12–24 months) at 
the time of publication.
 Discussion 
 Eccrine porocarcinoma, also known as 
malignant eccrine poroma, is a rare ad-
nexal tumor that accounts for 0.005% of 
epidermal skin neoplasms  [9] . Eccrine po-
rocarcinoma may occur de novo as a pri-
A B C
D E F
 Fig. 2. Histomorphologic aspects of eccrine porocarcinoma.  A Solid aggregates of invasive tumor cells growing 
deep into the dermis and adjacent subcutis.  B Areas of necrosis (stars) and prominent nuclear pleomorphism. 
 C Abnormal mitotic figures (arrow).  D Abortive ductal differentiation (arrow) is highlighted by carcinoem-
bryonic antigen immunostaining ( E , arrows).  F Focus of clear cell changes due to glycogen deposition (stars). 
Bars = 100   m. 
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mary tumor or, as in nearly 50% of cases, 
develop from preexisiting benign poromas 
after a long latency. The malignant trans-
formation may be induced by immuno-
suppression or ionizing radiation  [10] .
 Eccrine porocarcinomas are certainly 
rare skin malignancies, but the reported 
incidence may be an underestimation be-
cause many porocarcinomas are over-
looked or misinterpreted as squamous or 
basal cell carcinoma  [5] . Moreover, eccrine 
porocarcinomas may also resemble vari-
ous common benign skin tumors, includ-
ing verruca vulgaris or pyogenic granulo-
ma  [5, 7] , as was the case with our patients. 
Furthermore, Akiyoshi et al.  [8] described 
a single case of zosteriform tumor appear-
ance. Clinicians, therefore, need to be 
aware of this rare entity, as porocarcino-
mas often show a marked morphologic 
variability, which has led to misdiagnosis 
and delayed treatment with disastrous 
consequences in previously reported cases 
 [5–7] .
 Eccrine porocarcinoma of the head, as 
in our cases, is a rare clinical manifesta-
tion. The most common sites affected are 
the lower limbs, the trunk, abdomen or the 
upper extremities  [9] . Notably, some au-
thors reported eccrine porocarcinomas 
occurring in unusual localizations, like 
scars  [12] , the vulva, the scrotum, the penis 
or the periungual region  [13] . In areas ex-
hibiting a high density of eccrine sweat 
glands, like the palms or soles, porocarci-
nomas occur surprisingly seldom  [8] .
 The vast majority of patients with ec-
crine porocarcinomas are elderly people 
 [4] , although the tumor may also affect 
younger patients. Poiares Baptista et al.  [6] 
report on a case observed in a 12-year-old 
patient with xeroderma pigmentosum, 
and Valverde et al.  [14] report on an 8-
year-old girl with eccrine porocarcinoma, 
representing the youngest patient so far. A 
16-year-old Iraqi soldier, injured by a poi-
son gas explosion, developed metastatic 
porocarcinoma 8 years later, suggesting 
that eccrine porocarcinoma could be an 
additional variant in the spectrum of skin 
malignancies as late complications of con-
tact with poison gas  [15] .
 In addition, an association with lym-
phocyte dysfunction has been recognized 
in a previous report of an 81-year-old pa-
tient, and has been implicated in tumori-
genesis  [7] . Of particular interest in this 
case was the dysfunction of interleukin 2 
production and interleukin 2 receptor ex-
pression of peripheral lymphocytes, which 
have been related to the patient’s excep-
tional clinical manifestation with exten-
sive cutaneous metastasis. Similar obser-
vations, though uncommon, have been 
noted in some cases in previously pub-
lished series  [16, 17] . Taken together, the 
role of lymphocyte dysfunction in the de-
velopment of eccrine porocarcinoma is 
currently unclear, but it is interesting to 
note that 2 of our elderly patients also had 
disorders with functional lymphocyte im-
pairment, such as multiple myeloma and 
chronic lymphocytic leukemia.
 Although in some cases the diagnosis 
of eccrine porocarcinoma can be made on 
typical history and clinical findings (i.e. 
preexisting poroma), the definitive proof 
is histological. Deriving from the intraepi-
thelial ductal portion of eccrine sweat 
glands, histopathology reveals a tumor 
with ductal differentiation and significant 
cytologic pleomorphism. Eccrine poro-
carcinoma is most typically characterized 
by the downgrowth of broad anastomos-
ing bands of epithelium showing small ep-
ithelial cells united by small intercellular 
bridges and lacking any tendency towards 
peripheral palisading (dermal type). Oc-
casionally, the tumor grows horizontally 
and may produce extensive pagetoid infil-
tration in the overlying epidermis. This in-
traepidermal or epidermotropic type has 
been reported to exhibit a worse prognosis 
with either locally recurrent or metastatic 
disease  [18, 19] . It is standard practice to 
ascertain the origin of malignant cells by 
additional immunohistochemical stain-
ing. Thus, ductal differentiation and intra-
cytoplasmic lumen formation of eccrine 
porocarcinomas can be highlighted with 
the use of diastase-PAS reaction or the im-
munocytochemical demonstration of epi-
thelial membrane antigen or carcinoem-
bryonic antigen expression  [13] .
 Despite their sometimes innocuous 
histologic appearance, eccrine porocarci-
nomas are aggressive lesions, which re-
quire wide local excision of the primary 
tumor with dissection of regional lymph 
nodes if they are clinically involved  [4] . 
The role of an elective lymph node dissec-
tion, especially in recurrent or poorly dif-
ferentiated tumors, is still under debate. 
The recurrence rates in porocarcinomas 
after excision are approximately 20% and 
depend on completeness of removal, depth 
of tumor invasion ( 1 7 mm), and patholog-
ical grading  [4, 8, 11] . With regard to tu-
mor staging, a recent report highlights the 
diagnostic value of  18 F-fluorodeoxyglu-
cose positron emission tomography to de-
tect residual tumor, recurrent lesions and 
metastasis to regional lymph nodes or dis-
tant organs  [20] .
 The prognosis of eccrine porocarcino-
ma has been discussed controversially. 
Robson et al.  [4] presented the largest se-
ries of cases to date with a poor prognosis 
in 30% of the patients experiencing lymph 
node (20%) or distant metastases (10%). 
Akiyoshi et al.  [8] reviewed 21 cases with 
as many as 48% of patients developing me-
tastases. Matloub et al.  [21]  described the 
development of cutaneous, lymph node or 
visceral metastases in 39% of 79 reviewed 
cases. In contrast, Poiares Baptista et al.  [6] 
as well as Perna et al.  [11] each reported on 
only 1 out of 24 cases (4%), who developed 
metastases in the course of their disease. 
However, once the tumor has metasta-
sized, the outlook is poor, because no de-
finitive treatment exists. When lymph 
node metastases occur, the mortality rises 
up to approximately 65%  [4] . The survival 
time in 6 patients with distant metastases 
was 5–24 months  [3] . Radiotherapy seems 
of little benefit and systemic chemothera-
py is of uncertain value  [5, 22] , although 
responses of metastatic tumors have re-
cently been described after treatment with 
docetaxel (Taxotere)  [22] as well as pacli-
taxel (Taxol) combined with systemic im-
munotherapy (interferon   )  [23] . One case 
report indicated that metastatic porocar-
cinoma improved substantially with inter-
feron   and interleukin 2 injected perile-
sionally  [24] . There is, however, no evi-
dence to suggest a beneficial effect of an 
adjuvant therapy. Overall, careful follow-
up is needed in patients with eccrine poro-
carcinoma. None of our 5 cases has shown 
tumor recurrence, lymph node or distant 
metastases (18–30 months follow-up) so 
far, but a long-term follow-up is required.
 To summarize, the diagnosis of eccrine 
porocarcinoma may be delayed, especially 
in cases of atypical presentation, leading to 
protracted illness and serious complica-
tions. Even though rare, and diagnosed 
most often only by histology, our report 
highlights the fact that eccrine porocarci-
noma should enter the list of differential 
diagnosis when considering skin tumors 
in the elderly.
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